Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9015701 | Pharmacological Research | 2005 | 7 Pages |
Abstract
Treatment of neurodegenerative diseases represents a major challenge for the pharmaceutical industry. Key to developing novel and efficacious therapeutics is the discovery of new druggable targets. Toward this aim, the current drug discovery process is strongly relying on the improved understanding of disease mechanisms and on a synergistic approach with chemistry, molecular biology and robotics. In this scenario, we present the case of a newly discovered molecular mechanism that may be of interest for drug discovery programmes in Huntington's disease and other neurodegenerative diseases.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
Chiara Zuccato, Marzia Tartari, Donato Goffredo, Elena Cattaneo, Dorotea Rigamonti,